Press Release | Tissuepathology.com

Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine

Erica Goodpaster — Thu, 20 Aug 2026 12:56:06 +0000

Bioptimus to use Cancer Research Horizons’ data to train and evaluate its AI foundation model Third partnership since Bioptimus launched ground-breaking STELA initiative in March Deal adds Bioptimus’ first UK patient cohort to STELA, deepening its multimodal biology model Thursday August 20th 2026, Paris, FRANCE: Bioptimus, a global AI tech company pioneering the first world […]

The post Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine first appeared on Tissuepathology.com.

Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development

Erica Goodpaster — Wed, 19 Aug 2026 13:21:52 +0000

Imagene AI: Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs August 18, 2026 Imagene AI, a leader in AI-powered precision oncology, today announced that it has joined the Proscia Ready partner alliance. Imagene AI is collaborating with Proscia® to integrate its advanced […]

The post Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development first appeared on Tissuepathology.com.

Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth

Erica Goodpaster — Mon, 17 Aug 2026 12:19:28 +0000

Lumea: Company Recognized for Large Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses LEHI, UT, UNITED STATES, August 11, 2026 /EINPresswire/ — Lumea today announced it has been ranked No. 1,641 on the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. Lumea also ranked No. […]

The post Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth first appeared on Tissuepathology.com.

Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board

Erica Goodpaster — Fri, 14 Aug 2026 18:53:56 +0000

aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare solutions, officially began trading on the Taiwan Innovation Board on May 20 at an offering price of NT$23.12 per share. A listing ceremony and opening […]

The post Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board first appeared on Tissuepathology.com.

Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ

Erica Goodpaster — Fri, 14 Aug 2026 12:23:46 +0000

The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn assessments into structured, coded reports. OREM, UT, UNITED STATES, August 13, 2026 /EINPresswire.com/ — Techcyte today announced the availability of eleaDNAi, elea’s AI-native pathology reporting technology, into Techcyte Fusion®, the digital pathology platform that brings anatomic and clinical pathology into a […]

The post Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ first appeared on Tissuepathology.com.

Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software

Erica Goodpaster — Tue, 11 Aug 2026 12:56:37 +0000

Leica Biosystems: Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care VISTA, Calif., August 11, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced multiple U.S. Food and Drug Administration (FDA) 510(k) clearances […]

The post Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software first appeared on Tissuepathology.com.